Effect of alkan-1-ols on the structure of dopc model membrane

The effect of general anaesthetics alkan-1-ols (CnOH, where n = 10, 12, 14, 16 and 18 is the number of carbon atoms in the molecule) on the structure of dioleoylphosphatidylcholine (DOPC) model membrane was studied by small-angle neutron scattering (SANS) and small-angle neutron diffraction (SAND)....

Full description

Saved in:
Bibliographic Details
Main Authors: Kondela T. (Author), Gallová J. (Author), Hauß T. (Author), Ivankov O. (Author), Kučerka N. (Author), Balgavý P. (Author)
Format: Book
Published: Sciendo, 2017-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_55e663b4187c4b2c810e69ce70331eb4
042 |a dc 
100 1 0 |a Kondela T.  |e author 
700 1 0 |a Gallová J.  |e author 
700 1 0 |a Hauß T.  |e author 
700 1 0 |a Ivankov O.  |e author 
700 1 0 |a Kučerka N.  |e author 
700 1 0 |a Balgavý P.  |e author 
245 0 0 |a Effect of alkan-1-ols on the structure of dopc model membrane 
260 |b Sciendo,   |c 2017-11-01T00:00:00Z. 
500 |a 2453-6725 
500 |a 10.1515/afpuc-2017-0010 
520 |a The effect of general anaesthetics alkan-1-ols (CnOH, where n = 10, 12, 14, 16 and 18 is the number of carbon atoms in the molecule) on the structure of dioleoylphosphatidylcholine (DOPC) model membrane was studied by small-angle neutron scattering (SANS) and small-angle neutron diffraction (SAND). Fluid bilayers were prepared at CnOH:DOPC = 0.3 molar ratio. The results of both the experiments show that bilayer thickness - a thickness parameter dg in the case of SANS and lamellar repeat distance D in the case of SAND - increases with increasing n. A coexistence of two lamellar phases with different D was detected by measuring the C18OH+DOPC oriented sample. 
546 |a EN 
690 |a model membrane - general anaesthetics - alkan-1-ols - small-angle neutron scattering - small-angle neutron diffraction - structure 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n European Pharmaceutical Journal, Vol 64, Iss 2, Pp 4-8 (2017) 
787 0 |n https://doi.org/10.1515/afpuc-2017-0010 
787 0 |n https://doaj.org/toc/2453-6725 
856 4 1 |u https://doaj.org/article/55e663b4187c4b2c810e69ce70331eb4  |z Connect to this object online.